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Missing data is a common issue in research using observational studies to investigate the effect of treatments
on health outcomes. When missingness occurs only in the covariates, a simple approach is to use missing
indicators to handle the partially observed covariates. The missing indicator approach has been criticised
for giving biased results in outcome regression. However, recent papers have suggested that the missing
indicator approach can provide unbiased results in propensity score analysis under certain assumptions. We
consider assumptions under which the missing indicator approach can provide valid inferences, namely: (1)
no unmeasured confounding within missingness patterns; either (2a) covariate values of patients with miss-
ing data were conditionally independent of treatment; or (2b) these values were conditionally independent
of outcome; and (3) the outcome model is correctly specified: specifically, the true outcome model does
not include interactions between missing indicators and fully observed covariates. We prove that, under the
assumptions above, the missing indicator approach with outcome regression can provide unbiased estimates
of the average treatment effect. We use a simulation study to investigate the extent of bias in estimates
of the treatment effect when the assumptions are violated and we illustrate our findings using data from
electronic health records. In conclusion, the missing indicator approach can provide valid inferences for
outcome regression, but the plausibility of its assumptions must first be considered carefully.
Key words: average treatment effect; missing confounder data; missing covariate data; missing
indicator; outcome regression
1 Introduction
Observational studies are a valuable source of information for research investigating the efficacy and safety
of treatments in practice. We focus on scenarios where we want to estimate the effect of treatment on a
health outcome. However, a common challenge when using observational data is how to deal with missing
data. If not handled appropriately, missing data can lead to bias and a loss of efficiency (Bartlett et al.,
2015). When using observational data for research, missing data is often an issue in variables that may be
considered as potential confounders, such as smoking status or ethnicity.
The simplest approach for handling partially observed covariates is complete record analysis (also called
complete case analysis), where patients with missing data are excluded from analysis. Although complete
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record analysis can provide unbiased results (Bartlett et al., 2015), this approach will typically lead to
a loss of efficiency due to the exclusion of information. Furthermore, if patients with complete records
are not representative of the population of interest, results from a complete record analysis may not be
generalizable to the population of interest (Little and Rubin, 2002; Pigott, 2001).
A popular alternative missing data method is multiple imputation, where missing values are imputed
multiple times with plausible values in order to create multiple ‘complete’ imputed datasets. After analysing
each dataset, the results are combined using Rubin’s Rules to obtain an overall treatment effect estimate
(Rubin, 1976; Carpenter and Kenward, 2013). Although multiple imputation is very powerful, it can be
fairly complex and standard implementation requires the assumption that data are missing at random (i.e.
the probability of being missing depends on observed data and, given these, does not depend on unobserved
data) (Carpenter and Kenward, 2013; Seaman et al., 2013). The plausibility of the missing at random as-
sumption should be considered when implementing multiple imputation (Sterne et al., 2009). In addition,
imputing missing values in standard multiple imputation relies on parametric assumptions (Little and Ru-
bin, 2002), the plausibility of which should also be considered (Nguyen et al., 2017).
Another simple way of dealing with partially observed covariates is to use missing indicators — vari-
ables which indicate whether the covariate is missing or observed. For a continuous covariate, missing
observations are replaced with a fixed value, say 0, and a missing indicator is added to the analysis model,
alongside the continuous variable. For a categorical covariate, the missing indicator approach is equivalent
to adding a ‘missing’ category to the variable.
The use of missing indicators to handle missing covariates in outcome regression has been criticised in
the literature for being “ad hoc” (Vach and Blettner, 1991; Greenland and Finkle, 1995), and for giving
biased results (Groenwold et al., 2012; Jones, 1996). However, the missing indicator approach is often used
to deal with missing covariates (Knol et al., 2010) and has been recommended as a missing data method
for propensity score analysis (Stuart, 2010). Related methods, incorporating the last-observation-carried-
forward approach, have been studied in the context of non-systematic monitoring of covariates in settings
with time-varying treatments (Hernán et al., 2009; Kreif et al., 2018). Furthermore, our recent work in the
propensity score context suggests that the missing indicator approach can provide unbiased estimates under
certain assumptions (Blake et al., 2019). In propensity score analysis, we want to model the relationship
between the covariates and the treatment, whereas in outcome regression, we wish to model the relationship
between the covariates and the outcome. So, we need to investigate whether the validity of our findings
in the propensity score context also holds for outcome regression. Therefore, in this paper we consider
whether our work can be extended to the context of outcome regression.
We begin in Section 2 by describing the basic principles of the missing indicator approach and the
assumptions underlying its validity. In Section 3, we prove that the missing indicator approach can give
unbiased estimates of the treatment effect in outcome regression and show how our work fits in with the
literature. In Section 4, we explore the extent of bias in the estimation of the treatment effect when these
assumptions are violated. In Section 5, we apply the missing indicator approach in multivariable outcome
regression to an illustrative example. We conclude with a discussion in Section 6.
2 Background
2.1 Notation and potential outcome framework
Let Z be a binary variable indicating treatment allocation (or exposure status, etc. depending on context)
and let Y represent the observed outcome variable. In this paper, we will concentrate on missing data in
covariates and assume that treatment Z and outcome Y are fully observed, as the missing indicator method
does not accommodate missing data on the outcome or exposure.
To enable us to describe the assumptions underlying the missing indicator approach, we refer to the
potential outcome framework, developed by Rubin (1974) for causal inference from observational data.
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We let Y (z) represent the potential outcome that would be observed if Z was set equal to the value z
(z = 0, 1).
We focus on a scenario with two confounders: a fully observed confounder C and a partially observed
confounder X . The missing indicator R equals 1 if X is observed, and R = 0 if X is missing.
The confounder values can be partitioned as {Xobs, Xmis}, where Xobs is the set of X values that are
observed and Xmis is the set of missing X values (i.e. Xmis contains the true unobserved X values). For
each patient with R = 1, Xobs is equal to X and Xmis is empty. For each patient with R = 0, Xmis = X
and Xobs is empty. Additionally, we define X∗ = X when R = 1, and X∗ = 0 when R = 0. Note that
an alternative approach would be to define Xobs instead as RX (which is equivalent to X∗) and Xmis as
(1 − R)X . However, for the purposes of this paper, we use the Xobs and Xmis notation, following the
literature on which our theory builds (D’Agostino and Rubin, 2000; Mattei, 2009).
Our estimand of interest is the average treatment effect (ATE): E[Y (1)] − E[Y (0)]. To estimate the
treatment effect, we make the following standard assumptions for causal inference with complete data:
strongly ignorable treatment allocation, no interference, consistency, and positivity.
The Strongly Ignorable Treatment Allocation (SITA) assumption — an important assumption in causal
inference using observational data — is that there is no unmeasured confounding (Rosenbaum and Rubin,
1983). In a scenario with two confounders, C and X , the SITA assumption can be written as:
Z ⊥ Y (1), Y (0)|C,X. (1)
Under the assumption of no interference, the treatment status of one patient does not affect the potential
outcomes of another patient (Höfler, 2005; Hernán and Robins, 2018). Assuming consistency, the observed
outcome of a patient is equal to the potential outcome corresponding to the treatment they actually received,
i.e. if Z = z then Y = Y (z) (Hernán and Robins, 2018). Finally, under positivity, all patients have a non-
zero probability of being assigned to each value of treatment, given their characteristics (Little and Rubin,
2000; Hernán and Robins, 2018)
2.2 The missing indicator approach
The missing indicator approach is a simple method of dealing with partially observed covariates. When
using outcome regression, the missing indicator approach allows patients with missing data to be used for
the estimation of the treatment effect on the outcome, given covariates.
For a continuous partially observed covariate, the missing indicator approach in outcome regression
replaces missing covariate values with some fixed value: the same value (for example, 0) is used for all
participants with that covariate missing. Both the modified covariate and the missing indicator R are then
included in the analysis model. For a categorical partially observed covariate, the missing indicator ap-
proach is equivalent to adding a ‘missing’ category to the variable. The regression coefficient for treatment
can then be used to obtain an estimate of the treatment effect using appropriate transformations (eg. the
identity function for linear regression).
For example, using the missing indicator approach for linear regression, the analysis model is E[Y ] =
α0 +α1Z +α2C +α3X
∗ +α4R, where X∗ = X when R = 1, and X∗ = 0 when R = 0, and where α1
is the regresssion coefficient corresponding to our estimate of the ATE.
We note that, in the propensity score context, the missing indicator approach allows patients with miss-
ing data to contribute to the estimation of the propensity score (i.e. the probability of receiving treatment,
given patient characteristics). So, missing indicators are included in the propensity score model, rather
than the outcome model (which only includes treatment allocation and the propensity score as covariates).
2.2.1 Assumptions underlying the missing indicator approach
Our recent work in the context of propensity score analysis has shown that the missing indicator approach
relies on four assumptions (Blake et al., 2019). In this paper, we extend this work by investigating whether
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these four assumptions also underlie the validity of the missing indicator approach in outcome regression,
in order to understand when this approach is appropriate in practice.
The first assumption is that there is no unmeasured confounding within missingness patterns, i.e. within
each subgroup of patients who have information recorded on the same variables (Mattei, 2009). We call
this the missingness Strongly Ignorable Treatment Allocation (mSITA) assumption, due to the similarity
to the SITA assumption (equation (1)). Mathematically:
mSITA: Z ⊥ Y (z)|C,X,R for z = 0, 1. (2)
We call the second and third assumptions the Conditionally Independent Treatment (CIT) assumption
and the Conditionally Independent Outcomes (CIO) assumption, respectively. The CIT assumption is that
missing confounder values are conditionally independent of treatment, given the observed confounder val-
ues and the missing indicator, while the CIO assumption is that missing confounder values are conditionally
independent of the potential outcomes (Mattei, 2009).
CIT: Z ⊥ Xmis|C,Xobs, R. (3a)
CIO: Y (z) ⊥ Xmis|C,Xobs, R for z = 0, 1. (3b)
Note that in scenarios with partially observed confounders, the mSITA, CIT and CIO assumptions replace
the SITA assumption with respect to identification of the causal estimand.
The fourth assumption in the propensity score context is that the propensity score model is correctly
specified; in particular, we assume that the true propensity score model does not include an interaction
between the missing indicator R and the fully observed confounder C (CR interaction). In other words,
the effect of the fully observed confounder on treatment allocation is assumed to be the same for all miss-
ingness patterns.
The analogue assumption for outcome regression is that the outcome model is correctly specified and, in
particular, the true outcome model does not include a CR interaction. The plausibility of this correct spec-
ification assumption is context-dependent and can be assessed in the data at hand, allowing the possibility
of adapting the model in order to ensure the outcome model is correctly specified.
We can obtain valid inferences from the missing indicator approach in propensity score analysis under
the following sufficient assumptions: (i) the mSITA assumption holds; (ii) either the CIT or the CIO
assumption holds; and (iii) the propensity score model is correctly specified (Blake et al., 2019). In this
paper, we extend this work to the outcome regression context, demonstrating in Section 3 that we can
use the missing indicator approach with outcome regression to obtain valid inferences under the following
assumptions: (i) the mSITA assumption holds; (ii) either the CIT or the CIO assumption holds; and (iii)
the outcome model is correctly specified.
2.2.2 Plausibility of the assumptions underlying the missing indicator approach
In missing data methodology, when deciding if a particular method is appropriate, it is important to con-
sider the way in which data becomes missing, i.e. the missingness mechanism. Rubin’s taxonomy (Rubin,
1976) is commonly used to classify data as being missing completely at random, missing at random, or
missing not at random (Carpenter and Kenward, 2013; Little and Rubin, 2002).
The plausibility of the assumptions in Section 2.2.1 rely instead on the underlying structure of the
data (i.e. the causal associations between variables), rather than the missingness mechanisms (Blake et al.,
2019). For example, the CIT and CIO assumptions together mean that the partially observed confounder
does not confound the relationship between treatment and outcome when it is missing (Blake et al., 2019).
So, either the confounder-treatment relationship is absent in individuals who have missing confounder val-
ues or the confounder-outcome relationship is absent in individuals who have missing confounder values.
Hence, key violations of the CIT or CIO assumptions occur when the missing confounder values affect
treatment allocation or the outcome, respectively.
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If we believe that the SITA assumption (i.e. no unmeasured confounding) holds in full data, then the
mSITA assumption says that additionally conditioning on missingness patterns does not introduce bias.
One key way in which this can be violated is when there are: shared unmeasured common causes between
outcome and missingness, and unmeasured common causes between treatment and missingness. This is an
example of M-bias, which has been discussed extensively in the literature (Greenland, 2003; Pearl, 2009).
The correct specification assumption would be violated if the effects of fully observed confounders on
the outcome varied by missingness pattern. Unlike this parametric assumption, which can be tested in the
data, the mSITA, CIT and CIO assumptions are not testable. Instead, researchers should use substantive
knowledge of the given clinical setting to determine the plausibility of the mSITA, CIT and CIO assump-
tions.
The first step to assess the plausibility of these assumptions would be to consider whether it is clinically
plausible that X is only a confounder when it is observed. If so, and if key violations of the assumptions
can be ruled out, then researchers can construct a causal diagram to represent the underlying structural
assumptions for the given clinical setting (Blake et al., 2019). This causal diagram should include the
missing indicator R. The next step is to convert this causal diagram to incorporate potential outcomes
(Richardson and Robins, 2013; Balke and Pearl, 1994; Shpitser and Pearl, 2007). Then, the d-separation
rule – which determines whether variables are conditionally independent given a set of other variables
(Pearl, 1995; Richardson and Robins, 2013) – can be applied to the causal diagram to assess whether the
mSITA assumption holds. In order to assess the CIT and CIO assumptions, the causal diagram should be
restricted to patients with R = 0 and modified to reflect why it is plausible that X is only a confounder
when it is observed (Blake et al., 2019). The d-separation rule can then be applied to this final causal
diagram to assess the CIT and CIO assumptions.
For example, consider a simple scenario with a partially observed confounder X and a fully observed
confounderC, whereC also has causal effects on bothX andR. Further suppose that theX-Z relationship
is absent in patients with missing X values. Hence, it is plausible that X is only a confounder when it
is observed. Figure 1 shows a causal diagram representing this scenario, constructed in the form of a
single world intervention graph in order to incorporate potential outcomes (Richardson and Robins, 2013).
Applying the d-separation rule to Figure 1, as previously described (Richardson and Robins, 2013; Blake
et al., 2019), we find that Z is conditionally independent of Y (z) given C, X and R. Hence, the mSITA
assumption holds in this example. In order to be able to assess the CIT and CIO assumptions, we modify
Figure 1, by restricting to patients with R = 0 and removing the arrow from X to Z in order to encode
the assumption that the X-Z relationship is absent in patients with R = 0. Figure 2 shows this modified
causal diagram. Applying the d-separation rule to this diagram, we find that the CIT assumption holds and
that the CIO assumption is violated. Hence, in this scenario, the mSITA and CIT assumptions hold and the
missing indicator approach is considered appropriate.
When there are multiple partially observed confounders, R becomes a vector of the missing indicators,
whilst Xobs now represents all of the sets of observed confounder values and Xmis represents all sets
of missing confounder values. Assuming that the missingness of these confounders are not associated
with each other or with the other confounders, we can assess the CIT and CIO assumptions for each
confounder separately, but whilst conditioning on all sets of observed confounder values and all fully
observed confounders. An assumption only holds if it holds for every confounder. Issues may arise if
the missing indicator of one confounder changes the missing values of another confounder; however, this
seems unlikely. For complex scenarios, we recommend constructing a causal diagram that incorporates all
relevant substantive knowledge and a missing indicator for each partially observed confounder, and then
using software such as Dagitty (Textor et al., 2011) to assess the plausibility of the assumptions.
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3 Unbiased estimation of the average treatment effect
In this section we prove that, under the four assumptions given in Section 2.2.1, the missing indicator
approach in outcome regression can give an unbiased estimate of the average treatment effect (ATE). We
also explore how this result relates to the findings in the literature that the missing indicator approach gives
biased results (Jones, 1996), and how the assumptions relate to prior literature.
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Below in Section 3.1, we show that if the mSITA assumption holds and either the CIT assumption or
the CIO assumption holds, then:
E[Y (z)|C,Xobs, R] = E[Y (z)|Z,C,Xobs, R] (for z = 0, 1). (5)
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So, we can model the relationship between the outcome and C,Xobs, R in each of the two treatment
groups and — assuming that the outcome model is correctly specified — we can substitute estimates of
the conditional expectations in equation (6) to obtain an unbiased estimate of the ATE. Thus, under the
assumptions given in Section 2.2.1, we can get an unbiased estimate of the treatment effect by modelling
the relationship between outcome and treatment, given confounders and the missing indicator.
The missing indicator approach suggests a particular parametric specification of the outcome model, at
this stage. In particular, missing indicators are added as main effects only, thereby encoding the assump-
tion that there are no interactions between the missing indicators and fully observed confounders. These
parametric modelling assumptions can be assessed using the data at hand, although it is unclear whether
such checks are common in practice.
3.1 Proof of equation (5)
We first suppose the mSITA and CIT assumptions hold (equations (2) and (3a), respectively). For z = 0, 1,
we can write E[Y (z)|C,Xobs, R] (from equation (5)) in summation notation:∑
yP
(
















Under the mSITA assumption, the first probability in equation (7) can be written as
P
(
Y (z) = y|Z,Xmis, C,Xobs, R
)
, and under the CIT assumption, the second probability can be written
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as P(Xmis|Z,C,Xobs, R). So, for z = 0, 1, equation (7) becomes:∑∑
yP
(
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.
Alternatively, if the mSITA and CIO assumptions (equations (2) and (3b)) hold, for z = 0, 1, we write:∑
yP
(














where the denominator is strictly positive under the positivity assumption.
















Under the mSITA assumption, the first probability in equation (9) can be written as
P
(
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)
, and under the CIO assumption, the second probability can be written
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.
3.2 Connections to prior work on the missing indicator approach
Jones (1996) assumed that the true outcome model is a linear regression model with a fully observed
covariate Z, a single partially observed covariate X and independent normal errors ε:
Y = β0 + β1Z + β2X + ε, (10)
where ε is independent of (Z,X,R). Correspondingly, the missing indicator approach can be represented
mathematically as:
E[Y ] = γ0 + γ1Z + γ2X
∗ + γ3R. (11)
Jones (1996) showed that the least squares estimator of γ1 is biased for β1, noting that the least squares
estimator is unbiased when the sample covariance of Z and X , for patients missing X , is zero. If the CIT
assumption holds, this condition holds, since treatment allocation is independent of the confounder for
those patients with missing confounder values.
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The true outcome model assumed by Jones (1996) in equation (10) leads to the CIO assumption being
violated as the outcome is dependent on the missing confounder values. However, if the CIO assumption
does hold, then the true outcome model instead resembles the parametric model corresponding to the
missing indicator approach in equation (11) (i.e. the true model is Y = β0+β1Z+β2X∗+β3R+ ε), and
it is simple to show that the least squares estimator is unbiased.
Hence, our findings are compatible with Jones’s findings (1996). We have additionally shown that
the missing indicator approach can give unbiased estimates when the mSITA and CIO assumptions hold
(regardless of whether the CIT assumption additionally holds).
3.3 Connection to alternative statements of assumptions in the literature
The missing indicator method has been recommended for propensity score analysis (Stuart, 2010), based
on work in relation to the missingness pattern approach within propensity score analysis (Mattei, 2009;
D’Agostino and Rubin, 2000). This approach involves modelling the propensity score separately for each
pattern of missing confounder data and can be thought of as a generalisation of the missing indicator
method.
In Section 2.2.1, our statement of the mSITA, CIT and CIO assumptions follows Mattei (2009), who
states assumptions sufficient for valid inference for the missingness pattern approach. Our assumptions
differ from Mattei (2009) in that our version of the CIO assumption is slightly weaker, and requires the
conditional independence statement to hold separately for each potential outcome, rather than jointly for
the pair of potential outcomes as in the Mattei (2009) original presentation.
D’Agostino and Rubin (2000) instead provide the following assumption, sufficient for valid inference
in the missingness pattern approach:
Z ⊥ (Y (0), Y (1), Xmis)|Xobs, R. (12)
The mSITA and CIT assumptions imply that equation (12) holds. However, mSITA and CIO can hold
while equation (12) is violated. Thus Mattei (2009) gives a wider set of assumptions under which the
missingness pattern approach provides valid inference.
There are strong connections between the missingness pattern approach and other work exploring non-
systematic monitoring of time-varying covariates (Hernán et al., 2009; Kreif et al., 2018). These papers
suggest a version of the “no unmeasured confounding assumption” which, in the single time-point exposure
setting, can be written as:
Z ⊥ Y (z)|Xobs, R. (13)
Note that here, we have omitted fully observed confounders in order to simplify our discussion of the
connections between alternative statements of assumptions.
If the D’Agostino assumption holds, then assumption (13) holds. Further, if either the mSITA and CIT
assumptions hold, or the mSITA and CIO assumptions hold, then assumption (13) holds. Compared to the
D’Agostino assumption (12), therefore, the mSITA, CIT and CIO assumptions can be seen as a wider set
of assumptions under which variants of missingness-pattern-type approaches can produce valid inference.
The statement in equation (13) thus provides the most general of the three sets of assumptions.
Kreif et al. (2018) focus on the scenario where the partially missing (non-systematically monitored)
covariate is key to the treatment decision process and thus when the clinician does not have this covariate
information, they must rely on the last measurement available. Therefore, in their setting – in contrast
to our scenario – the covariate always contributes to the treatment decision, whether as an up-to-date
measurement or as the last available measurement. However, both settings lead to a causal structure which
satisfies a CIT-type assumption.
Here, we assume that full-data inference is the goal, i.e. if we were able to obtain full data then we
would. Kreif et al. (2018), in contrast, treat the monitoring process (which induces the missing covariate
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data) as an intrinsic part of the setting, and as an attribute of interest in its own right. In particular, in time-
varying settings the optimal treatment combination may depend on the intended monitoring process. This
makes the inferential goals of Kreif et al. (2018) quite different to those laid out in the current paper. In
particular, the set of assumptions we focus on (mSITA, CIT and CIO) require the investigator to consider
the confounding structure in the full data setting and how missingness arises in that setting (mSITA),
and then to subsequently explore how this structure may change when missing confounder values are
present (CIT/CIO). We have found this two-step process useful in considering plausibility of assumptions
in real-life settings. Furthermore, although identification of the ATE can be proved using a modification
of assumption (13), it may sometimes be more helpful to separate the relationship between the missing
confounder values and treatment allocation from the relationship between the missing confounder values
and the potential outcomes by considering the CIT and CIO as two separate sub-assumptions.
All three sets of assumptions make it clear that they are likely to be satisfied in a setting where missing
confounder values are unavailable to the individual making the treatment decision and thus do not affect
treatment. However, only the first version, with CIT and CIO as two separate sub-assumptions, makes it
clear that there is another quite different set of scenarios in which missingness-pattern-type methods may
provide valid inference.
4 Simulation Study
In this simulation study, we explored the extent of the bias introduced into the treatment effect estima-
tion when each of the key assumptions is violated. Source code to reproduce the results is available as
Supporting Information on the journal’s web page (http://onlinelibrary.wiley.com/doi/xxx/suppinfo).
4.1 Data-generating mechanisms
We considered 81 data-generating mechanisms. For each, datasets of sample size n = 500 were generated.
The data-generating mechanisms differed according to which of the assumptions hold. A factorial design
was used to consider all possible combinations of each assumption having no violation, a weak violation
or a strong violation.
We let UZ represent a common cause between treatment and the missing indicator, UY represent a com-
mon cause between the outcome and the missing indicator, and e represent error in the outcome regression
model. We generated UZ , UY and e from independent standard Normal distributions.
Two binary confounders X and C were generated using Binomial distributions: X ∼ Bin(1, 0.67) and
C ∼ Bin(1, 0.58). To create missing data in X , we generated a missing indicator R ∼ Bin(1,P(R = 0)),
where: logit(P(R = 0)) = −0.5 + 1.48 · UZ + 1.36 · UY .
We also generated a binary treatment allocation variable Z ∼ Bin(1,P(Z = 1)), where:
logit(P(Z = 1)) = −1.2 + αUZ + 1.38XR+ βX(1−R) + 2R+ 1.69C.
The observed proportion of treated patients varied between 62.2% and 86.2%, depending on the data-
generating mechanism. We generated a continuous outcome using the regression model:
Y = 1− 2.35Z − 2.2αUY − 1.55XR+ γX(1−R) + 1.8R− 1.7C + δCR+ 3e.
where α ∈ {0, 0.125, 1.25}, β ∈ {0, 0.138, 1.38}, γ ∈ {0,−0.155,−1.55} and δ ∈ {0,−0.42,−4.2}. If
α = 0, then the mSITA assumption holds. Similarly, if β = 0, γ = 0, or δ = 0, then, respectively, the
CIT assumption holds, the CIO assumption holds, or the outcome model is correctly specified. For each
parameter, the smaller and larger non-zero values represent, respectively, a weak violation and a strong
violation of the corresponding assumption.
Data were simulated using Stata 14.2 with 5000 simulation repetitions per data-generating mechanism.
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4.2 Methods
Each simulated data set was analysed using the missing indicator approach with multivariable linear regres-
sion, by creating a new version of the partially observed binary covariate with a third ‘missing’ category.
Our estimand is the average treatment effect, as estimated using the treatment coefficient from a linear
regression model. Our performance measure of interest is absolute bias of the ATE: 15000
∑5000
i=1 θ̂i − θ,
where θ̂i is the estimated treatment effect from the ith repetition, and θ is the true treatment effect.
4.3 Results
In Figure 3, the left-hand panel presents the absolute bias in the estimated treatment effect for eight sce-
narios, depicting all possible combinations of the mSITA, CIT and CIO assumptions holding or not. The
dark bars show scenarios where the mSITA assumption (required for valid inference) holds. The light bars
show scenarios where it does not. As expected from our theory above, if the mSITA assumption is violated
(light bars), bias is present. The four sets of bars show combinations of the CIT and CIO assumptions
holding or not, for scenarios where the mSITA assumption holds (dark bars); bias is present only when
both CIT and CIO are violated. The right-hand panel of Figure 3 shows the same eight scenarios, but with
a parametric violation of assumptions: the outcome model fitted assumes no interaction between the miss-
ingness indicator and the fully observed confounder C, but in truth this interaction does exist. Violation of
this parametric assumption leads to bias in all eight scenarios.
Figure 4 shows a number of scenarios in which the outcome model is correctly specified but the other
three assumptions (mSITA, CIT and CIO) may be violated. The three panels show – from left to right –
increasing levels of violation of the CIO assumption. Within the three panels, the three sets of bars show
– from left to right – increasing levels of violation of the CIT assumption. Within each set of bars, the
bars show – from left to right – increasing levels of violation of the mSITA assumption. Large bias is seen
when either a strong violation of the mSITA assumption is present, or when strong violations of both the
CIT and CIO assumptions are present.
Figure 5 shows the same scenarios as Figure 4, but with weak violations of the parametric assumptions
(weak CR interactions present but not included in the fitted model) shown in the top panel, and strong
violations of the parametric assumptions shown in the bottom. Weak violations of the parametric assump-
tions induced additional small amounts of bias compared to Figure 4. Strong violations of the parametric
assumptions induced large amounts of biases under most settings.
The missing indicator approach gives unbiased estimates of the treatment effect when the mSITA as-
sumption holds, the outcome model is correctly specified and either one, or both, of the CIT and CIO
assumptions hold. When both the CIT and CIO assumptions are violated, the missing indicator approach
gives biased results, whether or not the other two assumptions hold. The worst bias occurs when both
the mSITA assumption and the correct specification assumption is violated and the CIT assumption holds,
whether or not the CIO assumption holds. In general, having the mSITA assumption violated results in
larger biases for the settings explored in the simulation study. In addition, incorrectly specifying the out-
come model, i.e. failing to include an interaction between the fully observed confounder C and the missing
indicator R in the true outcome model, generally results in larger biases than when the outcome model is
correctly specified.
When the outcome model is correctly specified, weak violations of the other assumptions results in
similar biases compared to when the assumptions hold (Figure 4). Similar results were found when con-
sidering data-generating mechanisms where the true outcome model includes a weak CR interaction and
when considering data-generating mechanisms with a strong CR interaction (Figures 5a and 5b respec-
tively). In general, having a weak CR interaction resulted in similar or larger biases compared to scenarios
where the outcome model is correctly specified.
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5 Application to illustrative example
5.1 Study description
Our illustrative example is a cohort study using electronic health records data from the UK Clinical Practice
Research Datalink and the Hospital Episode Statistics (Mansfield et al., 2016). The cohort study aimed to
investigate the association between risk of acute kidney injury (AKI) and use of angiotensin-converting en-
zyme inhibitors or angiotensin receptor blockers (ACEI/ARBs), compared to other antihypertensive drugs.
An important covariate in the study was chronic kidney disease, which was categorised into stages based
on a continuous measure of kidney function called the estimated glomerular filtration rate (eGFR). Lower
values of eGFR indicate worse kidney function.
Data were obtained for 570 586 new adult users of antihypertensive drugs between 1997 and 2014.
Follow-up began at first prescription of ACEI/ARBs, beta blockers, calcium channel blockers, or diuretics.
The treatment of interest was prescription of ACEI/ARBs. Our outcome of interest was kidney function
within 2 months of first prescription of an antihypertensive drug, as measured using eGFR (Levey et al.,
2009). Due to conditions of the data use agreement, we can no longer access the eGFR data after treat-
ment initiation, so we have simulated this variable, based on observed relationships in prior studies (see
Appendix for details). As a result, the ‘true’ treatment effect is known.
In this study there were a number of fully observed potential confounders: age, sex, chronic comorbidi-
ties, other antihypertensive or diuretic drugs, and calendar period. In addition, two potential confounders
were partially observed: ethnicity, which had 59.0% missing data; and baseline eGFR category, which had
52.9% missing data.
In this example, only 21% of patients had complete data for both ethnicity and baseline eGFR category;
the majority of patients records would be discarded, leading to a loss of efficiency, if complete record
analysis was used for this example. Furthermore, standard multiple imputation may not be appropriate
since the missing at random assumption is questionable: baseline eGFR category is more likely to be
measured for patients with worse kidney function. The assumptions underlying the missing indicator
approach seem reasonable in this context. First, the mSITA assumption would be violated if there are any
unobserved common causes between missingness of baseline eGFR category and treatment allocation or
the outcome. In this example, it seems plausible that any such common causes, such as age or chronic
comorbidities, are measured and able to be included in the analysis model. In addition, predictors of
missingness in ethnicity seem unlikely to also be predictors of prescription decisions. Thus the mSITA
assumption seems plausible here.
Second, it is plausible to assume that information about a patient’s baseline eGFR category is unlikely
to influence the clinician’s decision to prescribe if this information is not available to the clinician (eg. if
a kidney function test had not been ordered beforehand). In practice, proxy information about a patient’s
baseline eGFR category may be available to the clinician (but not to researchers using electronic health
records). However, this is likely to reflect poor kidney function for only a small proportion of the whole
study population. In addition, it is plausible that a clinician would ensure information on patient’s ethnicity
is recorded if they believe that this information is an important factor in their decision whether or not to
prescribe ACEI/ARBs. Thus we believe that the CIT assumption is plausible.
Third, it seems plausible that the effect of the other fully observed risk factors on AKI would not
vary according to whether or not ethnicity and baseline eGFR category were measured. Furthermore, this
assumption can be tested in the data.
Fourth, the CIO assumption does not seem plausible in this context — since baseline kidney function
remains a risk factor for change in eGFR, whether or not baseline eGFR category is measured. Since we can
obtain valid inferences from the missing indicator approach when just one of the CIT and CIO assumptions
hold (in addition to the mSITA and correct specification assumptions holding), the CIO assumption being
violated is not an issue here; the mSITA, CIT and correct specification assumptions seem plausible and
thus the missing indicator approach is considered appropriate.
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5.2 Method
We applied linear regression, adjusted for ethnicity, baseline eGFR category and fully observed con-
founders (age category, sex, chronic comorbidities, and calendar period), to obtain estimates of the treat-
ment effect comparing patients prescribed ACEI/ARBs at start of follow-up time exposed to ACEI/ARBs
versus patients not prescribed ACEI/ARBs at baseline. To handle missing data in ethnicity and baseline
eGFR category, we applied complete record analysis and the missing indicator approach. Analysis was
conducted in Stata 14.2.
5.3 Results
Our results are given in Table 1. The missing indicator approach uses all missingness patterns; in addition
to the 121 527 patients with complete data, 112 142 patients had missing data for baseline eGFR category,
147 011 have ethnicity missing, and 189 906 had missing data for both. Using the missing indicator
approach, the estimated treatment effect was closer to the true treatment effect than the estimate from
complete record analysis. In addition, the complete record analysis estimate has a wider confidence interval
due to the exclusion of over 75% of the patient records. When interactions between the missing indicators
and the fully observed confounders are added into the regression model, the results do not change much
compared to the missing indicator approach (-0.6575, 95% CI: [-0.7424, -0.5567]), and so there is no
evidence of a violation of the parametric assumption.
6 Discussion
In this paper, we have shown that the missing indicator approach in outcome regression is unbiased when (i)
there is no unmeasured confounding within missingness patterns; (ii) either confounder values of patients
with missing data are conditionally independent of treatment assignment, or these missing confounder
values are conditionally independent of the outcome; and (iii) the effect of fully observed confounders
on the outcome is the same for all missingness patterns. We have applied the missing indicator approach
to an illustrative example using routinely collected data, a key area in which the method’s underlying
assumptions may be plausible (Blake et al., 2019).
An advantage of the missing indicator approach for outcome regression is that it is easy to implement
and, unlike complete record analysis, avoids discarding much information when the proportion of missing
data is large. In addition, the missing indicator approach may be appropriate in situations where multiple
imputation is not, as the missing indicator approach does not rely on the conventional classification of miss-
ingness mechanisms. Whereas standard implementation of multiple imputation is guaranteed to be valid
when data are missing at random, the CIT and CIO assumptions are not about the missingness mechanism,
but are rather about whether the partially observed covariate confounds the relationship between treatment
and outcome when it is missing. When either the CIT or the CIO assumption holds, the relationships
between variables among patients with observed data are not the same as those among patients with miss-
ing data, and so multiple imputation may not be appropriate. In contrast, the missing indicator approach
may be unbiased under missing not at random mechanisms, and biased under some missing completely at
random mechanisms.
The missing indicator approach has been criticised in the missing data methodology literature as being
‘ad hoc’ (Greenland and Finkle, 1995) and biased (Groenwold et al., 2012; Jones, 1996). We have shown
that the missing indicator approach can give unbiased results under certain assumptions. Researchers seek-
ing to use the missing indicator approach should first consider whether these assumptions seem plausible
within the context of a given clinical setting, with the help of causal diagrams. In our simulation study, we
considered scenarios with a single partially observed variable. Our suggested approach to handling mul-
tiple partially observed confounders within the missing indicator framework requires the assumption that
the missingness of one confounder does not affect the missing values of another confounder. In practice,
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researchers should carefully consider the plausibility of such an assumption, in addition to considering the
plausibility of the mSITA, CIT, CIO, and correct specification assumptions. If the assumptions underlying
the missing indicator approach are found to not be appropriate, then researchers should consider whether
the assumptions underlying complete record analysis or multiple imputation are more appropriate in the
given scenario.
The missing indicator approach is a method for handling missing covariate data, but cannot handle
missing data on the outcome or treatment allocation. Further work is required to extend the approach to
handle other missing data, perhaps by combining with other methods such as multiple imputation. Another
limitation of the missing indicator approach, in the context of propensity score analysis, is that estimation
issues may arise if there are many missingness patterns and some of these patterns have low sample size.
(Qu and Lipkovich, 2009) proposed a pattern-pooling algorithm to ensure sufficient sample size for esti-
mation in propensity score analysis. Further work is needed to explore the impact of low sample size in
missingness patterns in the context of outcome regression and whether this impact can be alleviated by
using pattern-pooling algorithms. A limitation of our simulation study is that we did not assess the impact
of changing the proportion of missing data. However, when the assumptions do not hold, bias is expected
to increase with the proportion of missing data. Furthermore, in this paper, we have focused on linear re-
gression. We believe that our theoretical results can be extended to risk difference estimation and Poisson
regression; further work is required to confirm this. Careful consideration would be required to translate
these results to the odds ratio setting due to non-collapsibility issues.
In conclusion, the missing indicator approach for outcome regression can be applied in a principled
way and can give valid results under a particular set of assumptions, but researchers must first consider
whether these assumptions seem plausible in the clinical setting of interest. We end by noting that standard
application of the missing indicator approach makes rather strong parametric assumptions about absence
of interactions between missing indicators and fully observed confounders; we recommend that checking
these assumptions in the data at hand should form part of routine practice when applying this approach.
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Appendix
A. Simulating kidney function for the illustrative example
We simulated a continuous outcome Y = Xβ + e where X denotes the design matrix, β represents
the vector of regression coefficients and e denotes the vector of error terms, where e ∼ (0, 14.65). The
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design matrix contains the vector with all entries equal to 1 and the following variables: prescription of
ACEI/ARBs at baseline; diabetes mellitus status at baseline; hypertension status at baseline; cardiac failure
status at baseline; arrhythmia status at baseline; ischaemic heart disease status at baseline; sex; ageband at
baseline; calendar period at baseline; ethnicity; and baseline eGFR category. The regression coefficients
are given in Table 2.
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Figure 1 A causal diagram for a simple scenario with a partially observed confounder X and a fully
observed confounder C, incorporating the missing indicator R. Y (z) is the potential outcome resulting
from intervening to set treatment Z to a particular value z.
Figure 2 A causal diagram for a simple scenario with a partially observed confounder X and a fully
observed confounder C, modified to assess the CIT and CIO assumptions. The square box around R = 0
indicates restriction to individuals with missing X values. Y (z) is the potential outcome resulting from
intervening to set treatment Z to a particular value z.
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Figure 3 Results from a simulation study showing the absolute bias in the estimated treatment effect
when using the missing indicator approach for multiple linear regression under different data-generating
mechanisms, which vary according to: (i) whether the mSITA assumption holds; (ii) whether the CIT
assumption holds; (iii) whether the CIO assumption holds; and (iv) whether there is an interaction between
the fully observed confounder C and the missing indicator R in the true outcome model. True treatment
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Figure 4 Results from a simulation study showing the absolute bias in the estimated treatment effect
when using the missing indicator approach for multiple linear regression under different data-generating
mechanisms, which vary according to whether there is no violation, a weak violation or a strong viola-
tion of: (i) the mSITA assumption, (ii) the CIT assumption, and (iii) the CIO assumption. For all data-
generating mechanisms, the outcome model is correctly specified. True treatment effect: −2.35. Sample
size: n = 500. Number of replications: 5000.
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(a) True outcome model includes weak CR interaction






































































(b) True outcome model includes strong CR interaction










Figure 5 Results from a simulation study showing the absolute bias in the estimated treatment effect when
using the missing indicator approach for multiple linear regression under different data-generating mech-
anisms, which vary according to whether there is no violation, a weak violation or a strong violation of:
(i) the mSITA assumption, (ii) the CIT assumption, and (iii) the CIO assumption. For all data-generating
mechanisms, the true outcome model contains either a weak interaction (5a) or a strong interaction (5b) be-
tween the fully observed confounder C and the missing indicator R. True treatment effect: −2.35. Sample
size: n = 500. Number of replications: 5000.
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Table 1 Estimated treatment effects (mean differences) and 95% confidence intervals (CIs) using linear
regression to compare the effect on (simulated) kidney function of being prescribed ACEI/ARBs at start of
follow-up versus not begin prescribed ACEI/ARBs at baseline. True treatment effect: -0.6831
Missing data method Treatment effect (95% CI) Number of patients analysed
Complete record analysis −0.6150 (−0.7977,−0.4324) 121 527
Missing indicator approach −0.6496 (−0.7424,−0.5567) 570 586
Table 2 Regression coefficients for using baseline characteristics to simulate an outcome variable
measuring kidney function within two months of prescription of antihypertensive drugs. ACEI/ARBs:
angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. eGFR: estimated glomerular
filtration rate.
Coefficient Variable Coefficient Variable
-0.6831 ACEI/ARBs prescription 1.3974 calendar period 2001− 2004
0.4847 diabetes mellitus 2.7825 calendar period 2005− 2008
-5.5041 hypertension 4.2181 calendar period 2009− 2011
-1.9321 cardiac failure 4.9409 calendar period 2012− 2014
-1.6349 arrhythmia 4.1883 ethnicity recorded as south asian
-3.4547 ischaemic heart disease -2.6490 ethnicity recorded as black
-1.6717 female 2.7238 ethnicity recorded as other
-12.8473 45 ≤ age < 55 3.3971 ethnicity recorded as mixed
-17.6097 55 ≤ age < 60 0.1647 ethnicity missing
-20.0686 60 ≤ age < 65 -36.7126 baseline eGFR < 30
-22.1784 65 ≤ age < 70 -25.1941 30 ≤ baseline eGFR < 45
-24.1881 70 ≤ age < 75 -16.3931 45 ≤ baseline eGFR < 60
-26.5288 75 ≤ age < 85 -4.4043 baseline eGFR missing
-25.6283 age ≥ 85 94.0335 constant
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